Evidence map›Paper›PMID 20005452›Full record

ArticleInternational journal of radiation oncology, biology, physics2010

Microsatellite instability predicts clinical outcome in radiation-treated endometrioid endometrial cancer.

Cristina Bilbao, Pedro Carlos Lara, Raquel Ramírez, Luis Alberto Henríquez-Hernández, Germán Rodríguez, Orlando Falcón, Laureano León, Manuel Perucho, Bonifacio Nicolás Díaz-Chico, Juan Carlos Díaz-Chico

Abstract read
In one paragraph

Article in International journal of radiation oncology, biology, physics, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed.

  1. Deciphering survival disparities in endometrial cancer: a focus on mismatch repair pathway integrity (systematic review and meta-analysis).Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2026
    Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Endometrial cancer: a genetic point of view.Translational cancer research · 2020
    Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Clinicopathologic Significance of Mismatch Repair Defects in Endometrial Cancer: An NRG Oncology/Gynecologic Oncology Group Study.Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2016
    Article
  16. Article
  17. Review
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Cristina BilbaoCanary Institute for Cancer Research, Las Palmas de Gran Canaria, Canary Islands, Spain. cbilbao@dbbf.ulpgc.es
Pedro Carlos Lara
Raquel Ramírez
Luis Alberto Henríquez-Hernández
Germán Rodríguez
Orlando Falcón
Laureano León
Manuel Perucho
Bonifacio Nicolás Díaz-Chico
Juan Carlos Díaz-Chico

Funding

MOLECULAR PATHOGENESIS OF CANCER OF MUTATOR PHENOTYPER37CA063585 · NCI · SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE · PI PERUCHO, MANUEL · 1999 to 2008
$7.0M
NCI NIH HHS R37 CA063585NCI NIH HHS R37 CA63585
6 · The paper itself

Abstract

purposeTo elucidate whether microsatellite instability (MSI) predicts clinical outcome in radiation-treated endometrioid endometrial cancer (EEC). METHODS AND MATERIALS: A consecutive series of 93 patients with EEC treated with extrafascial hysterectomy and postoperative radiotherapy was studied. The median clinical follow-up of patients was 138 months, with a maximum of 232 months. Five quasimonomorphic mononucleotide markers (BAT-25, BAT-26, NR21, NR24, and NR27) were used for MSI classification.

resultsTwenty-five patients (22%) were classified as MSI. Both in the whole series and in early stages (I and II), univariate analysis showed a significant association between MSI and poorer 10-year local disease-free survival, disease-free survival, and cancer-specific survival. In multivariate analysis, MSI was excluded from the final regression model in the whole series, but in early stages MSI provided additional significant predictive information independent of traditional prognostic and predictive factors (age, stage, grade, and vascular invasion) for disease-free survival (hazard ratio [HR] 3.25, 95% confidence interval [CI] 1.01-10.49; p = 0.048) and cancer-specific survival (HR 4.20, 95% CI 1.23-14.35; p = 0.022) and was marginally significant for local disease-free survival (HR 3.54, 95% CI 0.93-13.46; p = 0.064).

conclusionsThese results suggest that MSI may predict radiotherapy response in early-stage EEC.

Indexed as

Microsatellite InstabilityAdultAgedAged, 80 and overAge FactorsBiomarkers, TumorEndometrial NeoplasmsEpidemiologic MethodsFemaleGenetic MarkersHumansHysterectomyMiddle AgedNeoplasm Recurrence, LocalTreatment OutcomeBiomarkers, TumorGenetic Markers

Identifiers

PMID20005452
PMCPMC2796581

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.